1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 is sponsored by National Health and Medical Research Council (NHMRC) / Medical Research Future Fund (MRFF). This grant opportunity provides financial assistance to support medical research and innovation related to the post-acute sequelae of COVID-19.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research: Post-Acute Sequelae of COVID-19 Grant Opportunity - Grants. com. au Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research: Post-Acute Sequelae of COVID-19 Grant Opportunity Provider: National Health and Medical Research Council (NHMRC) Who can apply: Business, Community Co-contribution required: Not specified.
Sector: Healthcare, Medical, Biotechnology and Nanotechnology Interested in Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research: Post-Acute Sequelae of COVID-19 Grant Opportunity?
Purpose and Program Overview The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research: Post-Acute Sequelae of COVID-19 Grant Opportunity aims to facilitate and support medical research that enhances patient care and translates new discoveries into practical health benefits.
This program is specifically aligned with the Post-Acute Sequelae of COVID-19 (PASC) Research Plan, encouraging collaboration between researchers and consumers to address the ongoing health challenges posed by the condition.
The grant program is a component of the Australian Government’s $22 billion Medical Research Future Fund (MRFF), which serves as a long-term, sustainable source of funding for initiatives that improve health outcomes, quality of life, and the sustainability of the health system.
It plays a critical role in supporting the Australian medical research sector, driving innovation, and generating the necessary knowledge to inform clinical care, public policy, and the development of new diagnostic tools and therapies.
A total funding pool of up to $22 million was available for the 2023 grant opportunity, and up to $28 million was available for the 2024 grant opportunity, making a combined total of up to $50 million available for PASC research. Grant amount or funding range: Varies by stream. The 2023 opportunity offered grants from $0.
25 million up to $8 million. The 2024 opportunity offered grants from $0. 2 million up to $3 million.
Application open and close dates: The application period for both the 2023 and 2024 grant opportunities has now closed. Eligible industries or business types: Medical research, healthcare, and public health sectors. Required co-contributions: Not specified.
Location/state/territory applicability: The grants are for research that aims to improve the health and wellbeing of Australians. The grant is explicitly focused on the medical research and healthcare sectors. The priority area for funding is research into the Post-Acute Sequelae of COVID-19 (PASC), including its impacts on individuals, the healthcare system, and the development of new diagnostics or therapies.
The program is structured into two distinct grant opportunities, each with multiple funding streams: Stream 1 & 2: Up to $5 million for a maximum of five years. Stream 3: Between $0. 25 million and $1 million for a maximum of two years.
Stream 4 (Stage 1): Up to $0. 25 million for a maximum of one year. Stream 4 (Stage 2): Up to $8 million for a maximum of two years.
Stream 1: Between $0. 2 million and $1 million for a maximum of two years. Stream 2: Up to $3 million for a maximum of five years.
The grants are intended to fund research that improves patient care and encourages collaboration between consumers and researchers in the PASC field. Specific details regarding business structure, turnover, registered business location, or other compliance obligations were not provided, but are typically outlined in the official program guidelines.
Eligible Activities and Expenses The grants are designed to support a range of research activities that align with the PASC Research Plan. These activities include, but are not limited to: Research that improves understanding of the impacts of PASC on individuals and the community. Generating knowledge to support the development of novel diagnostic or monitoring tools.
Developing and testing new therapies for individuals living with PASC. Research to identify optimal management approaches for people with PASC. Improving the quality of care for individuals with PASC symptoms.
This grant program is competitive, with funding decisions made based on the merit of the proposed research. The key evaluation criteria are likely to include the project’s alignment with the PASC Research Plan, its potential to improve health outcomes for Australians, and the feasibility and rigour of the research design. The application periods for both the 2023 and 2024 grant opportunities have closed.
The application closing date for the most recent opportunity was 16 April 2025. There are no other recent updates specified in the provided information.
Double-check all eligibility criteria Prepare key documents in advance Align the proposal with government priorities Demonstrate capability, outcomes, and benefits Consider consulting a grant specialist for a personalised eligibility assessment and expert assistance in preparing a strong, compliant and competitive application.
Contact us today, and we will connect you with Australia’s best grant specialist, boasting over 35 years of experience in the industry and a 100% success rate. For official guidelines, application details, templates, and further information, visit the program’s official website and other associated Australian government websites.
Disclaimer: This grants search engine only searches for grants for businesses, and does not search for community grants or grants for not for profits. Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later. Preferences Reject Accept All Powered by (opens in a new window) Toggle Essential Essential Toggle Google reCAPTCHA Google reCAPTCHA Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Toggle Statistics Statistics Toggle Google Analytics Google Analytics Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions. Service URL: policies. google.
com (opens in a new window) Contains information related to marketing campaigns of the user. These are shared with Google AdWords / Google Ads when the Google Ads and Google Analytics accounts are linked together.
ID used to identify users and sessions 2 years after last activity 30 minutes after last activity Used to monitor number of Google Analytics server requests Used only with old Urchin versions of Google Analytics and not with GA. js. Was used to distinguish between new sessions and visits at the end of a session.
6 months after last activity 2 years after last activity Used to determine whether a user is included in an A / B or Multivariate test.
ID used to identify users Used to monitor number of Google Analytics server requests when using Google Tag Manager ID used to identify users for 24 hours after last activity ID used to identify users Used by Google Analytics to determine which links on a page are being clicked Powered by (opens in a new window)
According to the current listing, eligibility includes: Organisations conducting medical research and innovation. Universities are typically eligible administering institutions for MRFF grants. Confirm the full requirements in the official notice before applying.
The published deadline was September 2, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 is funded by National Health and Medical Research Council (NHMRC) / Medical Research Future Fund (MRFF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleOn September 4, 2026, HRSA awarded $11.2 million through the Rural Residency Planning and Development program to build 15 new physician residencies across 14 states. Since 2019 the program has invested nearly $77 million, producing 66 accredited programs and 818 approved positions. Here is what the conversion rate reveals, why the specialty mix is narrowing, and how to build a competitive application for the next cycle.
Read article